Stay updated on Pembrolizumab, Gemcitabine, Radiation for Bladder Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab, Gemcitabine, Radiation for Bladder Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab, Gemcitabine, Radiation for Bladder Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision updated from v3.3.1 to v3.3.2; no changes to study details, eligibility criteria, outcomes, or safety information were observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:53:27.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The page revision updated from v3.2.0 to v3.3.1. No substantive changes to the study details, eligibility criteria, or outcomes are evident.
    Difference
    0.1%
    Check dated 2025-11-24T14:42:04.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Removed the government funding lapse notice banner from the page, removing an operational alert without altering trial data or eligibility information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T06:52:30.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    The page content and layout appear unchanged between screenshots, with no additions or removals affecting the study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T01:16:19.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Updated core results content and data-sharing details have been added (new survival metrics, definitions, IPD sharing plans, and contact information), while older result-status language and some outdated items were removed.
    Difference
    16%
    Check dated 2025-10-12T14:30:31.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Major updates include a government funding status notice and an OS update to v3.2.0; the previous v3.1.0 tag was removed.
    Difference
    3%
    Check dated 2025-10-05T10:05:47.000Z thumbnail image

Stay in the know with updates to Pembrolizumab, Gemcitabine, Radiation for Bladder Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab, Gemcitabine, Radiation for Bladder Cancer Clinical Trial page.